TSE Explores Drug Discovery – Identifying and Optimizing a Promising Drug

As scientists learn more about the underlying causes of multiple sclerosis, they are developing intelligent interventions that slow or halt the progression of the disease. Learn more about the creation of zanimod (Zeposia), the first disease-altering MS therapy.

In this instalment of Teach Me in 10, Professor George Church, a pioneer of genomics and synthetic biology, treats us to a topic that he hasn't actually presented on publicly before: molecular and cellular multiplexing.

In this interview, Technology Networks speak with Professor Ardem Patapoutian, winner of this year’s Kavli Prize in Neuroscience, about his discovery of the Piezos, a family of pressure-sensitive ion channels with crucial roles in the body.